The Senate on Thursday voted to confirm trained surgeon and former daytime TV host Mehmet Oz as the next CMS administrator, ...
Drugmakers have leverage and are getting 'a real negotiation' with the government over the prices of products selected under ...
Providence Health Plan, which mainly operates in Oregon as part of West Coast health system Providence, said it’s working ...
Roche on Thursday shared early positive results for its Alzheimer’s candidate trontinemab, the latest round of data in its ...
SHL Medical opens $220M SC factory, DHL acquires Cryopdp, AGC forms new division, new facilities for NBE, Siemens-Miko Ghana ...
FDA rejects Aldeyra's dry eye drug reproxalap again, seeks more data. Company plans 2025 resubmission. AbbVie partnership ...
There were nine PIPEs in the first quarter of 2025, compared to 34 in the same quarter of last year, according to data shared ...
MoonLake Immunotherapeutics gets $75M upfront from Hercules Capital in $500M financing deal; OSR Holdings to sell $80M in ...
What was once a promising area of cancer immunotherapy has had another late-stage failure. BeiGene said Thursday ...
The FDA on Thursday approved Amgen’s rare disease drug Uplizna in an autoimmune disorder, setting the stage for the therapy to gain a foothold in the rare disease market.
A few cell and gene therapy biotechs are doing alright this week. The latest is Neurona Therapeutics, which exclusively told ...
The government fired three policy staffers who were responsible for understanding how to implement the Right to Try law.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback